Aneel A. Ashrani

Hematology

5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT.

Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT.

Journal: American journal of hematology

Published: January 15, 2026

Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT.

Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Haemostatic Prophylaxis and Colonoscopy Outcomes in Patients With Bleeding Disorders: An Update.

Haemostatic Prophylaxis and Colonoscopy Outcomes in Patients With Bleeding Disorders: An Update.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 23, 2025

The global epidemiology of acquired factor X deficiency.

The global epidemiology of acquired factor X deficiency.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 28, 2025

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers.

Assessment of classical hematologists and classical hematology fellowship programs at NCI-designated cancer centers.

Journal: Blood advances

Published: March 25, 2025

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 21, 2024

Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 05, 2024

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology.

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology.

Journal: American journal of clinical pathology

Published: August 30, 2024

The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events.

The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events.

Journal: Leukemia

Published: July 01, 2024

Histological Findings of ETosis in Hermansky-Pudlak Syndrome with Pulmonary Fibrosis: A Follow-Up Case Report.

Histological Findings of ETosis in Hermansky-Pudlak Syndrome with Pulmonary Fibrosis: A Follow-Up Case Report.

Journal: Journal of chest surgery

Published: June 03, 2024

Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.

Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 26, 2024

C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes.

C3+ and C3- warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes.

Journal: European journal of haematology

Published: January 13, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026